Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: A systematic review with meta-analysis of randomized controlled trials

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Palomba, Stefano ^a   Falbo, Angela ^a   La Sala, Giovanni B ^a,b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Gonadotropins; Infertility; Meta analysis; Metformin; PCOS; RCT

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; METFORMIN; PLACEBO;

AMENORRHEA; BIBLIOGRAPHIC DATABASE; BLOOD CHEMISTRY; CINAHL; CLINICAL EVALUATION; COCHRANE LIBRARY; DATA SYNTHESIS; DRUG EFFICACY; EMBASE; HUMAN; HYPERANDROGENISM; LIVE BIRTH; MEDLINE; META ANALYSIS; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BIRTH RATE; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; METFORMIN; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891915703     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-3     Document Type: Review

References (35)

1. Palomba S, Falbo A, Zullo F, Orio F. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 2009, 30:1-50. 10.1210/er.2008-0030, 19056992.
2. Palomba S, Falbo A, Russo T, Orio F, Tolino A, Zullo F. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response. Hum Reprod 2010, 25:1005-1013. 10.1093/humrep/dep466, 20106839.
3. Falbo A, Orio F, Venturella R, Rania E, Materazzo C, Tolino A, Zullo F, Palomba S. Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis. J Ovarian Res 2009, 31:2-5.
4. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996, 335:617-623. 10.1056/NEJM199608293350902, 8687515.
5. Sonnatag B, Götte M, Wülfing P, Schüring AN, Kiesel L, Greb RR. Metformin alters insulin signaling and viability of human granulosa cells. Fertil Steril 2003, 84:1173-1179.
6. Tosca L, Chabrolle C, Uzbekova S, Dupont J. Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5′ monophosphate-activated protein kinase (AMPK). Biol Reprod 2007, 76:368-378. 10.1095/biolreprod.106.055749, 17123942.
7. Palomba S, Russo T, Orio F, Falbo A, Manguso F, Sammartino A, Tolino A, Colao A, Carmina E, Zullo F. Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome. Hum Reprod 2006, 21:457-465.
8. Palomba S, Falbo A, La Sala GB. Effects of metformin in women with polycystic ovary syndrome treated with gonadotropins for in vitro fertilization and intracytoplasmatic sperm injection cycles: a systematic review and meta-analysis of randomized controlled trials. BJOG 2013, 120:267-276. 10.1111/1471-0528.12070, 23194199.
9. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008, 23:462-477. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
10. Beall SA, DeCherney A. History and challenges surrounding ovarian stimulation in the treatment of infertility. Fertil Steril 2012, 97:795-801. 10.1016/j.fertnstert.2012.02.030, 22463773.
11. Costello MF, Chapman M, Conway U. A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod 2006, 21:1387-1399. 10.1093/humrep/dei501, 16449310.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535. 10.1136/bmj.b2535, 2714657, 19622551, PRISMA Group.
13. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, Vanderpoel S, International Committee for Monitoring Assisted Reproductive Technology; World Health Organization; International Committee for Monitoring Assisted Reproductive Technology; World Health Organization International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology. Fertil Steril 2009, 92:1520-1524. 10.1016/j.fertnstert.2009.09.009, 19828144, International Committee for Monitoring Assisted Reproductive Technology; World Health Organization; International Committee for Monitoring Assisted Reproductive Technology; World Health Organization.
14. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, The Cochrane Collaboration, Available from http://www.cochrane-handbook.org.
15. Review Manager Version 5 http://ims.cochrane.org/revman.
16. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 4:719-748.
17. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
18. De Leo V, la Marca A, Ditto A, Morgante G, Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 1999, 72:282-285. 10.1016/S0015-0282(99)00208-3, 10438996.
19. Yarali H, Yildiz BO, Demirol A, Zeyneloǧlu HB, Yiǧit N, Bükülmez O, Koray Z. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial. Hum Reprod 2002, 17:289-294. 10.1093/humrep/17.2.289, 11821265.
20. Tasdemir S, Ficicioglu C, Yalti S, Gurbuz B, Basaran T, Yildirim G. The effect of metformin treatment to ovarian response in cases with PCOS. Arch Gynecol Obstet 2004, 269:121-124. 10.1007/s00404-002-0447-8, 12764624.
21. Palomba S, Falbo A, Orio F, Manguso F, Russo T, Tolino A, Annamaria C, Dale B, Zullo F. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. Hum Reprod 2005, 20:2879-2886. 10.1093/humrep/dei130, 15958399.
22. van Santbrink EJ, Hohmann FP, Eijkemans MJ, Laven JS, Fauser BC. Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment. Eur J Endocrinol 2005, 152:611-617. 10.1530/eje.1.01866, 15817918.
23. Cheng J, Lv J, Li CY, Xue Y, Huang Z, Zheng W. Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome. J Int Med Res 2010, 38:1250-1258. 10.1177/147323001003800406, 20925997.
24. Begum MR, Akhter S, Ehsan M, Begum MS, Khan F. Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. J Obstet Gynaecol Res 2013, 39:966-973. 10.1111/j.1447-0756.2012.02072.x, 23379651.
25. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19:41-47. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.
26. Zawadzki JK, Dunaif A, et al. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic ovary syndrome 1992, 337-384. Boston: Blackwell.
27. Legro RS. Metformin as adjuvant therapy to IVF in women with PCOS: when is intention-to-treat unintentional?. Hum Reprod 2011, 26:2043-2044. 10.1093/humrep/der155, 21606132.
28. Falbo A, Rocca M, Russo T, D'Ettore A, Tolino A, Zullo F, Orio F, Palomba S. Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin. J Ovarian Res 2010, 3:16. 10.1186/1757-2215-3-16, 2912910, 20663178.
29. Coyral-Castel S, Tosca L, Ferreira G, Jeanpierre E, Rame C, Lomet D, Caraty A, Monget P, Chabrolle C, Dupont J. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats. J Neuroendocrinol 2008, 20:335-346. 10.1111/j.1365-2826.2007.01643.x, 18194429.
30. Bilodeau-Goeseels S, Magyara N, Collignon C. Characterization of the effects of metformin on porcine oocyte meiosis and on AMP-activated protein kinase activation in oocytes and cumulus cells. Zygote 2013, 12:1-11.
31. Reverchon M, Cornuau M, Cloix L, Ramé C, Guerif F, Royère D, Dupont J. Visfatin is expressed in human granulosa cells: regulation by metformin through AMPK/SIRT1 pathways and its role in steroidogenesis. Mol Hum Reprod 2013, 19:313-326. 10.1093/molehr/gat002, 23315983.
32. Rice S, Elia A, Jawad Z, Pellatt L, Mason HD. Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab 2013, 98:E1491-E1500. 10.1210/jc.2013-1865, 3784648, 23846817.
33. Carvajal R, Rosas C, Kohan K, Gabler F, Vantman D, Romero C, Vega M. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients. Hum Reprod 2013, 28:2235-2244. 10.1093/humrep/det116, 23595973.
34. Banerjee P, Bhonde RR, Pal R. Diverse roles of metformin during peri-implantation development: revisiting novel molecular mechanisms underlying clinical implications. Stem Cells Dev 2013, 22:2927-2934. 10.1089/scd.2013.0171, 23786328.
35. Fulghesu AM, Romualdi D, Di Florio C, Sanna S, Tagliaferri V, Gambineri A, Tomassoni F, Minerba L, Pasquali R, Lanzone A. Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. Hum Reprod 2012, 27:3057-3066. 10.1093/humrep/des262, 22786777.